Dechra Pharmaceuticals PLC — AGM Information 2023

Dec 13, 2023

National Storage Mechanism | Additional information

RNS Number : 6772W

Dechra Pharmaceuticals PLC

13 December 2023

Wednesday 13 December 2023

Dechra® Pharmaceuticals PLC

Results of Annual General Meeting (AGM)

A poll was held on each of the resolutions proposed at the Annual General Meeting (AGM) of the Company held today

(13 December 2023).  All resolutions were passed and are as follows:

Resolution (No. as noted on proxy form)	Total For (includes Discretionary)		Total Against		Total Cast (excludes Withheld)		Withheld (1)
	No. of votes	% of vote	No. of votes	% of vote	No. of votes	% of ISC	No. of votes
Ordinary Business:
Resolution 1: To receive the accounts, the Strategic Report, the Directors' Report and the Auditor's Report	34,668,215	99.59%	114,234	0.41%	34,832,449	30.58%	771,171
Resolution 2: To approve the Directors' Remuneration Report	34,271,513	96.43%	1,269,735	3.57%	35,541,248	31.20%	62,372
Resolution 3: To approve the Directors' Remuneration Policy	34,214,987	96.11%	1,384,440	3.89%	35,599,427	31.25%	4,193
Resolution 4: To elect Geeta Gopalan	35,046,317	98.46%	549,509	1.54%	35,595,826	31.25%	7,794
Resolution 5: To re-elect Alison Platt	33,364,271	95.14%	1,704,836	4.86%	35,069,107	30.79%	534,513
Resolution 6: To re-elect Ian Page	34,750,073	97.61%	850,111	2.39%	35,600,184	31.26%	3,436
Resolution 7: To re-elect Anthony Griffin	Withdrawn		Withdrawn		Withdrawn		Withdrawn
Resolution 8: To re-elect Paul Sandland	35,440,108	99.55%	160,660	0.45%	35,600,768	31.26%	2,852
Resolution 9: To re-elect Lisa Bright	34,477,141	96.84%	1,123,690	3.16%	35,600,831	31.26%	2,789
Resolution 10: To re-elect Lawson Macartney	34,477,798	96.85%	1,123,033	3.15%	35,600,831	31.26%	2,789
Resolution 11: To re-elect John Shipsey	34,476,316	96.85%	1,123,044	3.15%	35,599,360	31.25%	4,260
Resolution 12: To re-appoint PricewaterhouseCoopers as external auditor of the company	34,995,995	98.30%	603,736	1.70%	35,599,731	31.25%	3,889
Resolution 13: To authorise the Audit Committee to determine the remuneration of the external auditor	35,535,808	99.82%	65,691	0.18%	35,601,499	31.26%	2,121
Special Business:
Resolution 14: To authorise the directors to allot shares to specific limits	34,107,454	95.91%	1,453,390	4.09%	35,560,844	31.22%	42,776
Resolution 15: To disapply the pre-emption rights	35,431,245	99.94%	19,551	0.06%	35,450,796	31.12%	152,824
Resolution 16: To disapply additional pre-emption rights	34,837,484	98.27%	613,429	1.73%	35,450,913	31.12%	152,707
Resolution 17: To authorise the Company to purchase its own shares	35,005,559	98.45%	549,788	1.55%	35,555,347	31.22%	48,273
Resolution 18: To authorise the Company to hold any general meeting (other than an AGM) on not less than 14 clear days' notice	33,696,131	94.66 %	1,901,511	5.34%	35,597,642	31.25%	5,978

Notes:

1.     A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" and "Against" a resolution.

2.     Resolutions 1 to 14 were ordinary resolutions, requiring more than 50% of shareholder votes to be "For" the resolutions.

3.     Resolutions 15 to 18 were special resolutions, requiring more than 75% of shareholder votes to be "For" the resolutions.

4.     Issued Share Capital at meeting date: 113,902,022

5.     Equiniti, Registrar to the Company, were appointed for the purpose of the Poll taken at the AGM and certify as scrutineer that the result of the Poll is correctly set out above.

In accordance with Listing Rule 9.6.2R, a copy of the resolutions passed as special business at the AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

For further information, please contact:

Melanie Hall

Company Secretary

Dechra Pharmaceuticals PLC

Telephone: +44 (0) 1606 814 730

Email: corporate.enquiries@dechra.com 

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide.  For more information, please visit: www.dechra.com.

Trademarks

Trademarks appear throughout this document in italics.  Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGFFIFEDEDSEDE